We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-1.81%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5.56B
AUM Growth
+$94.2M
(+1.7%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
5.28%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
4,002
New
390
Increased
2,050
Reduced
771
Closed
169
Avg Time Held Equity + Options
4.8
years
Top 10 Avg Time Held Equity + Options
3.5
years
Top 20 Avg Time Held Equity + Options
4.4
years
Avg Time Held Equity only
4.8
years
Top 10 Avg Time Held Equity only
3.5
years
Top 20 Avg Time Held Equity only
4.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$160M |
| 2 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$59.5M |
| 3 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$57M |
| 4 |
JPMorgan International Bond Opportunities ETF
JPIB
|
+$43M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$19.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$180M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$51M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$3.59M |
| 4 |
CVB Financial
CVBF
|
+$3.2M |
| 5 |
iShares International Select Dividend ETF
IDV
|
+$3.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.36% |
| 2 | Technology | 16.32% |
| 3 | Healthcare | 6.92% |
| 4 | Financials | 6.46% |
| 5 | Communication Services | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
Mesa Laboratories
MLAB
$690M
| $2.39K | ﹤0.01% |
+27
| New | +$2.33K |
2026 Q1
0 quarters
|
|
3277
Broadstone Net Lease
BNL
$3.48B
| $2.38K | ﹤0.01% |
130
-28
| -18% | -$527 |
2022 Q2
15 quarters
|
|
3278
Himalaya Shipping
HSHP
$761M
| $2.37K | ﹤0.01% |
178
| – | – |
2025 Q4
1 quarter
|
|
3279
FuelCell Energy
FCEL
$1.02B
| $2.36K | ﹤0.01% |
+362
| New | +$2.79K |
2026 Q1
0 quarters
|
|
3280
Richtech Robotics
RR
$290M
| $2.36K | ﹤0.01% |
1,129
| – | – |
2025 Q4
1 quarter
|
|
3281
Alto Ingredients
ALTO
$270M
| $2.35K | ﹤0.01% |
+486
| New | +$1.54K |
2026 Q1
0 quarters
|
|
3282
Skeena Resources
SKE
$3.9B
| $2.35K | ﹤0.01% |
+79
| New | +$2.43K |
2026 Q1
0 quarters
|
|
3283
Midland States Bancorp
MSBI
$672M
| $2.34K | ﹤0.01% |
105
| – | – |
2020 Q2
23 quarters
|
|
3284
Townsquare Media
TSQ
$70.6M
| $2.34K | ﹤0.01% |
431
+13
| +3% | +$82 |
2022 Q1
16 quarters
|
|
3285
New Mountain Finance
NMFC
$633M
| $2.33K | ﹤0.01% |
300
| – | – |
2018 Q4
29 quarters
|
|
3286
NexPoint Residential Trust
NXRT
$468M
| $2.33K | ﹤0.01% |
93
-20
| -18% | -$573 |
2017 Q1
36 quarters
|
|
3287
Karat Packaging
KRT
$1.07B
| $2.32K | ﹤0.01% |
+83
| New | +$2.09K |
2026 Q1
0 quarters
|
|
3288
Beam Therapeutics
BEAM
$2.41B
| $2.31K | ﹤0.01% |
97
| – | – |
2020 Q4
21 quarters
|
|
3289
AMN Healthcare
AMN
$1.57B
| $2.31K | ﹤0.01% |
+126
| New | +$2.4K |
2026 Q1
0 quarters
|
|
3290
Northwest Bancshares
NWBI
$2.19B
| $2.31K | ﹤0.01% |
182
| – | – |
2017 Q2
35 quarters
|
|
3291
Mechanics Bancorp
MCHB
$3.17B
| $2.29K | ﹤0.01% |
+155
| New | +$2.29K |
2026 Q1
0 quarters
|
|
3292
AB Disruptors ETF
FWD
$3.22B
| $2.28K | ﹤0.01% |
+21
| New | +$2.36K |
2026 Q1
0 quarters
|
|
3293
Astronics
ATRO
$2.65B
| $2.27K | ﹤0.01% |
41
+7
| +21% | +$423 |
2023 Q1
12 quarters
|
|
3294
Harmony Biosciences
HRMY
$2.24B
| $2.27K | ﹤0.01% |
81
-19
| -19% | -$623 |
2023 Q4
9 quarters
|
|
3295
Dave Inc
DAVE
$4.57B
| $2.26K | ﹤0.01% |
+13
| New | +$2.52K |
2026 Q1
0 quarters
|
|
3296
Atlanticus Holdings
ATLC
$1.4B
| $2.26K | ﹤0.01% |
43
+40
| +1,333% | +$2.24K |
2025 Q2
3 quarters
|
|
3297
VanEck High Yield Muni ETF
HYD
$4.05B
| $2.26K | ﹤0.01% |
45
| – | – |
2023 Q1
12 quarters
|
|
3298
Kforce
KFRC
$909M
| $2.25K | ﹤0.01% |
77
-777
| -91% | -$23.6K |
2025 Q1
4 quarters
|
|
3299
T. Rowe Price US Equity Research ETF
TSPA
$4.58B
| $2.25K | ﹤0.01% |
55
| – | – |
2025 Q2
3 quarters
|
|
3300
Kymera Therapeutics
KYMR
$8.76B
| $2.25K | ﹤0.01% |
27
+7
| +35% | +$554 |
2023 Q4
9 quarters
|
|
Similar funds
Parallel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Parallel Advisors held 4,002 positions worth $5.56B, up 1.7% from $5.47B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors deployed $293M of net new capital in Q1 2026, opening 390 new positions and adding to 2,050 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 48% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $180M trimmed.
- Parallel Advisors's largest Q1 2026 buy was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $160M increase.
- Parallel Advisors's biggest Q1 2026 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $180M.
- Parallel Advisors fully exited iShares 1-3 Year International Treasury Bond ETF in Q1 2026, selling an estimated $741K.
- Parallel Advisors's ten largest holdings make up 36% of its $5.56B portfolio in Q1 2026.
- Parallel Advisors opened 390 new positions and closed 169 in Q1 2026.
- Parallel Advisors's portfolio value rose 1.7% quarter-over-quarter to $5.56B.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.